Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions
<p dir="ltr">As global life expectancy increases, the prevalence of neurodegenerative diseases like Alzheimer’s disease (AD) continues to rise. Since therapeutic options are minimal, a deeper understanding of the pathophysiology is essential for improved diagnosis and treatments. AD...
Saved in:
| Main Author: | Sama Ayoub (15430987) (author) |
|---|---|
| Other Authors: | Maryam Arabi (3927509) (author), Yousef Al-Najjar (14147835) (author), Ibrahim Laswi (14787432) (author), Tiago F. Outeiro (191379) (author), Ali Chaari (827168) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease
by: Ahmad Raza (18205961)
Published: (2025) -
Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
by: Naila Rabbani (291722)
Published: (2020) -
AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
by: Naila Rabbani (291722)
Published: (2022) -
Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
by: Jinit, Masania
Published: (2023) -
Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
by: Jinit Masania (7164239)
Published: (2023)